US3534017A
(en)
|
1967-03-14 |
1970-10-13 |
Kyowa Hakko Kogyo Kk |
Process for the preparation of nucleoside-5'-diphosphates and triphosphates and mono- and oligo-nucleotidyl-nucleoside-5'-diphosphates and triphosphates
|
US4210746A
(en)
|
1978-08-10 |
1980-07-01 |
National Research Development Corporation |
Nucleotide inhibitor of protein synthesis
|
US4285605A
(en)
|
1979-07-02 |
1981-08-25 |
International Business Machines Corporation |
Escapement mechanism and backspace mechanism for a moving paper carriage typewriter having dual pitch capability
|
FR2471785A1
(fr)
|
1979-12-21 |
1981-06-26 |
Fabre Sa Pierre |
Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
|
DE3023787A1
(de)
|
1980-06-25 |
1982-01-21 |
Studiengesellschaft Kohle mbH, 4330 Mülheim |
Verfahren zur erhoehung der inkorporation und der expression von genetischem material in die kerne von intakten zellen mit hilfe von liposomen
|
EP0081099A3
(en)
|
1981-12-04 |
1983-08-10 |
Sloan-Kettering Institute For Cancer Research |
Capped oligonucleotide anti-viral agents
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US5194428A
(en)
|
1986-05-23 |
1993-03-16 |
Worcester Foundation For Experimental Biology |
Inhibition of influenza virus replication by oligonucleotide phosphorothioates
|
US5264423A
(en)
|
1987-03-25 |
1993-11-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibitors for replication of retroviruses and for the expression of oncogene products
|
WO1989008146A1
(en)
|
1988-02-26 |
1989-09-08 |
Worcester Foundation For Experimental Biology |
Inhibition of htlv-iii by exogenous oligonucleotides
|
JP2976436B2
(ja)
|
1988-04-27 |
1999-11-10 |
味の素株式会社 |
新規オリゴリボヌクレオチド誘導体及び抗ウイルス剤への使用
|
EP0339842B1
(en)
|
1988-04-27 |
1996-11-06 |
Isis Pharmaceuticals, Inc. |
Novel oligoribonucleotide derivatives and application thereof to antiviral agents
|
DE3907562A1
(de)
|
1989-03-09 |
1990-09-13 |
Bayer Ag |
Antisense-oligonukleotide zur inhibierung der transaktivatorzielsequenz (tar) und der synthese des transaktivatorproteins (tat) aus hiv-1 und deren verwendung
|
JPH04507402A
(ja)
|
1989-05-18 |
1992-12-24 |
マイクロプローブ・コーポレーション |
架橋オリゴヌクレオチド
|
US5134066A
(en)
|
1989-08-29 |
1992-07-28 |
Monsanto Company |
Improved probes using nucleosides containing 3-dezauracil analogs
|
ATE157012T1
(de)
|
1989-11-03 |
1997-09-15 |
Univ Vanderbilt |
Verfahren zur in vivo-verabreichung von funktionsfähigen fremden genen
|
WO1994002501A1
(en)
|
1992-07-23 |
1994-02-03 |
Isis Pharmaceuticals, Inc. |
Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
|
US5149797A
(en)
|
1990-02-15 |
1992-09-22 |
The Worcester Foundation For Experimental Biology |
Method of site-specific alteration of rna and production of encoded polypeptides
|
BR9106258A
(pt)
|
1990-03-21 |
1993-04-06 |
Isis Pharmaceuticals Inc |
Processos para modular a expressao de um gene,para tratar uma doenca,um animal ou uma infeccao e para interferir com a funcao ou replicacao de um virus e oligonucleotideo ou analogo de oligonucleotideo
|
US5292875A
(en)
|
1990-04-20 |
1994-03-08 |
Lynx Therapeutics, Inc. |
Method of synthesizing sulfurized oligonucleotide analogs
|
US5166195A
(en)
|
1990-05-11 |
1992-11-24 |
Isis Pharmaceuticals, Inc. |
Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
|
IL99069A
(en)
|
1990-08-09 |
1998-08-16 |
Genta Inc |
Methyphosphonate oligonucleotides associated with psoralen
|
AU652577B2
(en)
|
1990-08-14 |
1994-09-01 |
Isis Pharmaceuticals, Inc. |
Inhibition of influenza virus type A, Ann Arbor strain H2N2 by antisense oligonucleotides
|
US5271941A
(en)
|
1990-11-02 |
1993-12-21 |
Cho Chung Yoon S |
Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases
|
DE4110085A1
(de)
|
1991-03-27 |
1992-10-01 |
Boehringer Ingelheim Int |
2'-o-alkyl-oligoribonukleotide, verfahren zu deren herstellung und deren verwendung als antisense-oligonukleotide
|
WO1992017484A1
(en)
|
1991-03-27 |
1992-10-15 |
Research Corporation Technologies, Inc. |
Single-stranded circular oligonucleotides
|
US5646267A
(en)
|
1991-08-05 |
1997-07-08 |
Polish Academy Of Sciences |
Method of making oligonucleotides and oligonucleotide analogs using phospholanes and enantiomerically resolved phospholane analogues
|
US6369209B1
(en)
|
1999-05-03 |
2002-04-09 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having A-DNA form and B-DNA form conformational geometry
|
US7119184B2
(en)
|
1991-08-12 |
2006-10-10 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having A-DNA form and B-DNA form conformational geometry
|
ATE221127T1
(de)
|
1991-10-15 |
2002-08-15 |
Isis Pharmaceuticals Inc |
Über chirale phosphoratome gebundene oligonukleotide
|
NZ244820A
(en)
|
1991-10-25 |
1994-01-26 |
Isis Pharmaceuticals Inc |
Oligonucleotide inhibitor of epstein-barr virus.
|
FR2685346B1
(fr)
|
1991-12-18 |
1994-02-11 |
Cis Bio International |
Procede de preparation d'arn double-brin, et ses applications.
|
US5644048A
(en)
|
1992-01-10 |
1997-07-01 |
Isis Pharmaceuticals, Inc. |
Process for preparing phosphorothioate oligonucleotides
|
CA2135646A1
(en)
|
1992-05-11 |
1993-11-25 |
Kenneth G. Draper |
Method and reagent for inhibiting viral replication
|
US5606049A
(en)
|
1992-06-03 |
1997-02-25 |
Genta Incorporated |
Method of preparing 2'-O-methyl cytidine monomers useful in oligomer synthesis
|
TW244371B
(ru)
|
1992-07-23 |
1995-04-01 |
Tri Clover Inc |
|
US5652355A
(en)
|
1992-07-23 |
1997-07-29 |
Worcester Foundation For Experimental Biology |
Hybrid oligonucleotide phosphorothioates
|
US6346614B1
(en)
|
1992-07-23 |
2002-02-12 |
Hybridon, Inc. |
Hybrid oligonucleotide phosphorothioates
|
IL108206A0
(en)
|
1993-01-06 |
1994-04-12 |
Univ Johns Hopkins |
Oligomers having improved stability at acid ph
|
DE69400208T2
(de)
|
1993-01-25 |
1996-11-28 |
Hybridon Inc |
Olionukleotidalkylphosphonate und -phosphonothioate
|
AU6632094A
(en)
|
1993-04-19 |
1994-11-08 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
|
FR2705099B1
(fr)
|
1993-05-12 |
1995-08-04 |
Centre Nat Rech Scient |
Oligonucléotides phosphorothioates triesters et procédé de préparation.
|
CA2166890A1
(en)
|
1993-07-19 |
1995-02-02 |
Nanibhushan Dattagupta |
Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens
|
JPH0799976A
(ja)
|
1993-09-30 |
1995-04-18 |
Takeda Chem Ind Ltd |
修飾オリゴヌクレオチド
|
US5801235A
(en)
|
1994-05-25 |
1998-09-01 |
Hybridon, Inc. |
Oligonucleotides with anti-cytomegalovirus activity
|
CA2191192A1
(en)
|
1994-05-27 |
1995-12-07 |
Wayne M. Galbraith |
Use of oligonucleotide phosphorothioate for depleting complement and for reducing blood pressure
|
US5866699A
(en)
|
1994-07-18 |
1999-02-02 |
Hybridon, Inc. |
Oligonucleotides with anti-MDR-1 gene activity
|
JPH10505094A
(ja)
|
1994-09-07 |
1998-05-19 |
ハイブリドン・インコーポレイテッド |
オリゴヌクレオチドプロドラッグ
|
US5591721A
(en)
|
1994-10-25 |
1997-01-07 |
Hybridon, Inc. |
Method of down-regulating gene expression
|
JPH08154687A
(ja)
|
1994-12-12 |
1996-06-18 |
Yamanouchi Pharmaceut Co Ltd |
アンチセンスオリゴヌクレオチド及び抗ウイルス剤
|
WO1996018736A2
(en)
|
1994-12-13 |
1996-06-20 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses
|
CA2208528A1
(en)
|
1994-12-22 |
1996-06-27 |
Hybridon, Inc. |
Synthesis of stereospecific oligonucleotide phosphorothioates
|
US6111095A
(en)
|
1995-06-07 |
2000-08-29 |
Merck & Co., Inc. |
Capped synthetic RNA, analogs, and aptamers
|
GB9511720D0
(en)
|
1995-06-09 |
1995-08-02 |
Isis Innovation |
Oligonucleotide phosphorylation method and products
|
US20040234999A1
(en)
|
1996-04-02 |
2004-11-25 |
Farrar Gwenyth Jane |
Genetic suppression and replacement
|
US6127535A
(en)
|
1997-11-05 |
2000-10-03 |
Ribozyme Pharmaceuticals, Inc. |
Nucleoside triphosphates and their incorporation into oligonucleotides
|
EP1626086A2
(en)
|
1998-04-20 |
2006-02-15 |
Ribozyme Pharmaceuticals, Inc. |
Double-stranded nucleic acid molecules with novel chemical compositions capable of modulating gene expression
|
EP1493818A3
(en)
|
1998-04-29 |
2006-02-15 |
Ribozyme Pharmaceuticals, Inc. |
Nucleoside triphosphates and their incorporation into ribozymes
|
AU751480B2
(en)
|
1998-04-29 |
2002-08-15 |
Ribozyme Pharmaceuticals, Inc. |
Nucleoside triphosphates and their incorporation into ribozymes
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
US6344323B1
(en)
|
1998-09-16 |
2002-02-05 |
Vitagenix, Inc. |
Compositions and methods for inhibiting cox-2 expression and treating cox-2 associated disorders by using cox-2 antisense oligonucleotides
|
WO2001016312A2
(en)
|
1999-08-31 |
2001-03-08 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid based modulators of gene expression
|
ATE333284T1
(de)
|
1999-09-27 |
2006-08-15 |
Coley Pharm Group Inc |
Verfahren mittels durch nukleinsäuren induziertes immunostimulatorisches interferon
|
US20020028784A1
(en)
|
2000-03-10 |
2002-03-07 |
Nest Gary Van |
Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
|
DE10013600A1
(de)
|
2000-03-18 |
2002-01-10 |
Aventis Res & Tech Gmbh & Co |
Reaktive Monomere für die Oligonucleotid- und Polynucleotidsynthese, modifizierte Oligonucleotide und Polynucleotiden und ein Verfahren zu deren Herstellung
|
US6686461B1
(en)
|
2000-03-22 |
2004-02-03 |
Solulink Bioscience, Inc. |
Triphosphate oligonucleotide modification reagents and uses thereof
|
US20030077609A1
(en)
|
2001-03-25 |
2003-04-24 |
Jakobsen Mogens Havsteen |
Modified oligonucleotides and uses thereof
|
US6900308B2
(en)
|
2001-07-16 |
2005-05-31 |
Isis Pharmaceuticals, Inc. |
α-modified nucleoside triphosphates
|
AU2002329667A1
(en)
|
2001-07-30 |
2003-02-17 |
Uta Griesenbach |
Specific inhibition of gene expression by small double stranded rnas
|
FR2832154B1
(fr)
|
2001-11-09 |
2007-03-16 |
Centre Nat Rech Scient |
Oligonucleotides inhibiteurs et leur utilisation pour reprimer specifiquement un gene
|
US20030203868A1
(en)
|
2002-02-06 |
2003-10-30 |
Bushman Frederic D. |
Inhibition of pathogen replication by RNA interference
|
US7285658B2
(en)
|
2002-02-28 |
2007-10-23 |
Biota, Inc. |
Nucleotide mimics and their prodrugs
|
JP2005526778A
(ja)
|
2002-03-15 |
2005-09-08 |
アストラル,インコーポレイテッド |
免疫調節性非コードrnaモチーフを用いて抗体及び主要組織適合性クラスi拘束性又はクラスii拘束性t細胞の応答を開始或いは増強させるための組成物及び方法
|
US8153141B2
(en)
|
2002-04-04 |
2012-04-10 |
Coley Pharmaceutical Gmbh |
Immunostimulatory G, U-containing oligoribonucleotides
|
US20050222061A1
(en)
|
2002-04-18 |
2005-10-06 |
Schulte Ralf W |
Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
|
US20060088837A1
(en)
|
2002-04-26 |
2006-04-27 |
Kazunari Taira |
Expression system for stem-loop rna molecule having rnai effect
|
CA2388049A1
(en)
|
2002-05-30 |
2003-11-30 |
Immunotech S.A. |
Immunostimulatory oligonucleotides and uses thereof
|
ATE435303T1
(de)
|
2002-08-12 |
2009-07-15 |
New England Biolabs Inc |
Verfahren und zusammensetzungen in verbindung mit gen-silencing
|
US7109316B2
(en)
|
2002-08-23 |
2006-09-19 |
Ce Healthcare Bio-Sciences Corp. |
Oligonucleotide tagged nucleoside triphosphates (OTNTPs) for genetic analysis
|
JP2005537015A
(ja)
|
2002-09-04 |
2005-12-08 |
ジョンソン アンド ジョンソン リサーチ プロプライアトリー リミテッド |
RNA干渉(RNAi)を媒介するためにdsDNAを使用する方法
|
EP1578760B1
(en)
|
2002-09-11 |
2014-02-12 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
EP1560931B1
(en)
|
2002-11-14 |
2011-07-27 |
Dharmacon, Inc. |
Functional and hyperfunctional sirna
|
US7250496B2
(en)
|
2002-11-14 |
2007-07-31 |
Rosetta Genomics Ltd. |
Bioinformatically detectable group of novel regulatory genes and uses thereof
|
US20130130231A1
(en)
|
2002-11-26 |
2013-05-23 |
Isaac Bentwich |
Bioinformatically detectable group of novel viral regulatory genes and uses thereof
|
US7217807B2
(en)
|
2002-11-26 |
2007-05-15 |
Rosetta Genomics Ltd |
Bioinformatically detectable group of novel HIV regulatory genes and uses thereof
|
US7696334B1
(en)
|
2002-12-05 |
2010-04-13 |
Rosetta Genomics, Ltd. |
Bioinformatically detectable human herpesvirus 5 regulatory gene
|
EP1998177A3
(en)
|
2003-01-06 |
2009-02-18 |
Wyeth |
Compositions and methods for diagnosing and treating colon cancers
|
WO2004074441A2
(en)
|
2003-02-19 |
2004-09-02 |
Government Of The United States Of America Represented By The Secretary Department Of Health And Human Services |
Amplification or overexpression of mll septin-like fusion (msf) and septin9 and methods related thereto
|
CN1176937C
(zh)
|
2003-02-21 |
2004-11-24 |
复旦大学附属中山医院 |
一种双链rna及其用途
|
US20040261149A1
(en)
|
2003-02-24 |
2004-12-23 |
Fauquet Claude M. |
siRNA-mediated inhibition of gene expression in plant cells
|
US7381410B2
(en)
|
2003-03-12 |
2008-06-03 |
Vasgene Therapeutics, Inc. |
Polypeptide compounds for inhibiting angiogenesis and tumor growth
|
US7585967B2
(en)
|
2003-03-12 |
2009-09-08 |
Vasgene Therapeutics, Inc. |
Nucleic acid compounds for inhibiting angiogenesis and tumor growth
|
WO2004083430A2
(en)
|
2003-03-21 |
2004-09-30 |
Santaris Pharma A/S |
SHORT INTERFERING RNA (siRNA) ANALOGUES
|
WO2004085623A2
(en)
|
2003-03-24 |
2004-10-07 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
A compact synthetic expression vector comprising double-stranded dna molecules and methods of use thereof
|
US8969543B2
(en)
|
2003-04-03 |
2015-03-03 |
Bioneer Corporation |
SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof
|
US20050042641A1
(en)
|
2003-05-27 |
2005-02-24 |
Cold Spring Harbor Laboratory |
In vivo high throughput selection of RNAi probes
|
EP1633871A4
(en)
|
2003-06-03 |
2010-02-17 |
Benitec Australia Ltd |
DOUBLE-STRUCTURED NUCLEIC ACID
|
US20060166914A1
(en)
|
2003-06-06 |
2006-07-27 |
Dainippon Sumitomo Pharma Co., Ltd |
Method of nucleic acid infusion
|
ES2569927T3
(es)
|
2003-06-11 |
2016-05-13 |
Idera Pharmaceuticals, Inc. |
Oligonucleótidos inmunomoduladores estabilizados
|
FR2857013B1
(fr)
|
2003-07-02 |
2005-09-30 |
Commissariat Energie Atomique |
Petits arn interferents specifiques des sous-unites alpha, alpha prime et beta de la proteine kinase ck2 et leurs applications
|
US8372966B2
(en)
|
2003-12-19 |
2013-02-12 |
University Of Cincinnati |
Oligonucleotide decoys and methods of use
|
AU2005213464A1
(en)
|
2004-02-06 |
2005-08-25 |
Wyeth |
Diagnosis and therapeutics for cancer
|
US20050182005A1
(en)
|
2004-02-13 |
2005-08-18 |
Tuschl Thomas H. |
Anti-microRNA oligonucleotide molecules
|
US20070265220A1
(en)
|
2004-03-15 |
2007-11-15 |
City Of Hope |
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
|
AU2005222965B8
(en)
|
2004-03-15 |
2010-07-01 |
City Of Hope |
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
|
EP1750775A2
(en)
|
2004-05-04 |
2007-02-14 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
|
US20060035815A1
(en)
|
2004-05-04 |
2006-02-16 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical compositions for delivery of ribonucleic acid to a cell
|
US20070218079A1
(en)
|
2004-05-12 |
2007-09-20 |
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. |
Method to induce rnai in prokaryotic organisms
|
WO2006002538A1
(en)
|
2004-07-02 |
2006-01-12 |
Protiva Biotherapeutics, Inc. |
Immunostimulatory sirna molecules and uses therefor
|
WO2006016574A1
(ja)
|
2004-08-12 |
2006-02-16 |
Kumamoto University |
RNAiを利用した抗腫瘍剤
|
DE602004032245D1
(de)
|
2004-11-16 |
2011-05-26 |
Qiagen Gmbh |
Genabschaltung (Gene silencing) durch hybride Sens-DNA und Antisens-RNA Konstrukte, gekoppelt an ein Peptid zur erleichterten Aufnahme in Zellen
|
JP4981681B2
(ja)
|
2004-12-09 |
2012-07-25 |
アルナイラム ファーマシューティカルズ, インコーポレイテッド |
哺乳類における免疫応答誘導組成物および方法、ならびに短鎖干渉rnaなどのオリゴヌクレオチド剤に対する免疫応答の回避方法
|
CA2593238C
(en)
|
2005-01-07 |
2014-11-18 |
State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Method to trigger rna interference
|
WO2006078646A2
(en)
|
2005-01-18 |
2006-07-27 |
Caltagirone Gaetano T |
A class of supramolecular drug molecules and methods of identification and use thereof
|
US20060178334A1
(en)
|
2005-02-04 |
2006-08-10 |
City Of Hope |
Double-stranded and single-stranded RNA molecules with 5 ' triphosphates and their use for inducing interferon
|
US7998684B2
(en)
|
2005-02-07 |
2011-08-16 |
Takeda Pharmaceutical Company Limited |
Screening method for an agent for treatment of neurodegenerative disease
|
JP4645234B2
(ja)
|
2005-03-03 |
2011-03-09 |
和光純薬工業株式会社 |
架橋剤、それを用いた架橋方法、遺伝子発現調節方法および遺伝子機能調査方法
|
AU2006230436B2
(en)
|
2005-03-31 |
2011-11-24 |
Calando Pharmaceuticals, Inc. |
Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
|
US7893244B2
(en)
|
2005-04-12 |
2011-02-22 |
Intradigm Corporation |
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
|
WO2006110813A2
(en)
|
2005-04-12 |
2006-10-19 |
Intradigm Corporation |
Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases
|
US20070066521A1
(en)
|
2005-04-13 |
2007-03-22 |
Fauquet Claude M |
Short RNA-binding proteins
|
WO2006119643A1
(en)
|
2005-05-12 |
2006-11-16 |
Replicor Inc. |
Anti-ocular angiogenesis molecules and their uses
|
WO2006122409A1
(en)
|
2005-05-16 |
2006-11-23 |
Replicor Inc. |
Antimicrobial molecules and their uses
|
JP5371424B2
(ja)
|
2005-06-01 |
2013-12-18 |
ポリプラス トランスフェクション エスアー |
Rna干渉のためのオリゴヌクレオチドおよびその生物学的適用
|
WO2006130949A1
(en)
|
2005-06-08 |
2006-12-14 |
Replicor Inc. |
Anti amyloid-related disease molecules and their uses
|
CA2614531C
(en)
|
2005-07-07 |
2015-06-16 |
Avraham Hochberg |
Nucleic acid agents for downregulating h19, and methods of using same
|
CA2619533C
(en)
|
2005-08-17 |
2014-02-04 |
Bioneer Corporation |
Sirna-hydrophilic polymer conjugates for intracellular delivery of sirna and method thereof
|
JP2009507852A
(ja)
|
2005-09-08 |
2009-02-26 |
エムディーアールエヌエー,インコーポレイテッド |
リボ核酸の細胞への送達用医薬組成物
|
EP1924284A1
(en)
|
2005-09-14 |
2008-05-28 |
Hartmann, Gunther |
Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides
|
EP1764107A1
(en)
|
2005-09-14 |
2007-03-21 |
Gunther Hartmann |
Compositions comprising immunostimulatory RNA oligonucleotides and methods for producing said RNA oligonucleotides
|
WO2007038788A2
(en)
|
2005-09-29 |
2007-04-05 |
The Cleveland Clinic Foundation |
Small interfering rnas as non-specific drugs
|
US8101741B2
(en)
|
2005-11-02 |
2012-01-24 |
Protiva Biotherapeutics, Inc. |
Modified siRNA molecules and uses thereof
|
EP1957648B1
(en)
|
2005-11-17 |
2014-04-23 |
Board of Regents, The University of Texas System |
Modulation of gene expression by oligomers targeted to chromosomal dna
|
CA2634046A1
(en)
|
2005-12-12 |
2007-06-21 |
The University Of North Carolina At Chapel Hill |
Micrornas that regulate muscle cell proliferation and differentiation
|
EP1973574B1
(en)
|
2005-12-30 |
2014-04-02 |
Institut Gustave Roussy |
Use of inhibitors of scinderin and/or of ephrin-a1 for treating tumors
|
EP2004141A2
(en)
|
2006-03-17 |
2008-12-24 |
Novosom AG |
An efficient method for loading amphoteric liposomes with nucleic acid active substances
|
KR101221589B1
(ko)
|
2006-04-07 |
2013-01-15 |
이데라 파마슈티칼즈, 인코포레이티드 |
Tlr7 및 tlr8에 대한 안정화된 면역 조절성 rna〔simra〕 화합물
|
ES2360738T3
(es)
|
2006-06-01 |
2011-06-08 |
Trilink Biotechnologies |
Cebadores de oligonucleótidos modificados químicamente para la amplificación de ácido nucleico.
|
US20080091005A1
(en)
|
2006-07-20 |
2008-04-17 |
Visigen Biotechnologies, Inc. |
Modified nucleotides, methods for making and using same
|
EP2046954A2
(en)
|
2006-07-31 |
2009-04-15 |
Curevac GmbH |
NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
|
EP4082551A1
(en)
|
2006-08-08 |
2022-11-02 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Structure and use of 5' phosphate oligonucleotides
|
JP5407862B2
(ja)
|
2006-10-04 |
2014-02-05 |
サントル・ナシオナル・ドゥ・ラ・ルシェルシュ・シアンティフィーク(セーエヌエールエス) |
siRNAおよび脂質性4,5−二置換2−デオキシストレプタミン環アミノグリコシド誘導体を含む組成物ならびにその用途
|
EP2338499A1
(en)
|
2006-10-10 |
2011-06-29 |
Gunther Hartmann |
5' triphosphate oligonucleotide induces anti-viral response
|
WO2008045576A2
(en)
|
2006-10-12 |
2008-04-17 |
Yijia Liu |
Compositions and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases
|
CN101190944A
(zh)
|
2006-12-01 |
2008-06-04 |
北京诺赛基因组研究中心有限公司 |
人类新细胞因子及其用途
|
US20130005028A1
(en)
|
2006-12-21 |
2013-01-03 |
Smith Larry R |
Activation of RIG-I Pathway
|
CA2672937A1
(en)
|
2006-12-21 |
2008-06-26 |
Intradigm Corporation |
Inhibitory polynucleotide compositions and methods for treating cancer
|
US7858772B2
(en)
|
2006-12-22 |
2010-12-28 |
Roche Molecular Systems, Inc. |
Compounds and methods for synthesis and purification of oligonucleotides
|
CA2675967A1
(en)
|
2007-01-16 |
2008-07-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M |
Nucleic acid constructs and methods for specific silencing of h19
|
US9249423B2
(en)
|
2007-02-02 |
2016-02-02 |
Yale University |
Method of de-differentiating and re-differentiating somatic cells using RNA
|
WO2008099396A1
(en)
|
2007-02-15 |
2008-08-21 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Use of h19-silencing nucleic acid agents for treating restenosis
|
WO2008102728A1
(ja)
|
2007-02-19 |
2008-08-28 |
Kyoto University |
核酸導入用導電性基板および核酸導入方法
|
MY173854A
(en)
|
2007-03-13 |
2020-02-25 |
Malaysian Palm Oil Board |
Expression regulatory elements
|
WO2008124165A2
(en)
|
2007-04-09 |
2008-10-16 |
Chimeros, Inc. |
Self-assembling nanoparticle drug delivery system
|
CN101088565A
(zh)
|
2007-04-17 |
2007-12-19 |
华东师范大学 |
miRNA-34a的用途
|
CN101289486B
(zh)
*
|
2007-04-18 |
2012-05-30 |
上海吉凯基因化学技术有限公司 |
一种合成rna单体的方法
|
WO2008134593A1
(en)
|
2007-04-25 |
2008-11-06 |
President And Fellows Of Harvard College |
Molecular circuits
|
CA2684724A1
(en)
|
2007-05-01 |
2008-11-06 |
Santaris Pharma A/S |
Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
|
US9109012B2
(en)
|
2007-05-29 |
2015-08-18 |
Nature Technology Corporation |
Vectors and method for genetic immunization
|
TR201000668T1
(tr)
|
2007-07-31 |
2010-06-21 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Neoplasti̇k veya enfeksi̇yoz bozukluklara yöneli̇k i̇mmunoprofi̇laksi̇ veya i̇mmünoterapi̇ i̇çi̇n poli̇pepti̇d-nüklei̇k asi̇t konjugati
|
US8367815B2
(en)
|
2007-08-28 |
2013-02-05 |
California Institute Of Technology |
Modular polynucleotides for ligand-controlled regulatory systems
|
WO2009038707A2
(en)
|
2007-09-17 |
2009-03-26 |
Ludwig Institute For Cancer Research , Ltd. |
Cancer-testis gene silencing agents and uses thereof
|
CN103242444A
(zh)
|
2007-10-11 |
2013-08-14 |
大学健康网络 |
调节SIRPα-CD47相互作用以增加造血干细胞植入和用于此的化合物
|
US20100210710A1
(en)
|
2007-10-12 |
2010-08-19 |
Intradigm Corporation |
THERAPEUTIC siRNA MOLECULES FOR REDUCING VEGFR1 EXPRESSION IN VITRO AND IN VIVO
|
DE102007052114B4
(de)
|
2007-10-30 |
2011-01-05 |
T2Cure Gmbh |
Verfahren zur Modulation der Funktion, des Wachstums oder der Differenzierung einer Zelle
|
MX2010004984A
(es)
|
2007-11-05 |
2010-07-29 |
Baltic Technology Dev Ltd |
Uso de oligonucleotidos con bases modificadas en hibridacion de acidos nucleicos.
|
ES2545963T3
(es)
|
2007-11-06 |
2015-09-17 |
Sirnaomics, Inc. |
Terapéutica con ARNi multidirigidos para la cicatrización de heridas de la piel sin cicatriz
|
ES2530215T3
(es)
*
|
2007-11-06 |
2015-02-27 |
Adiutide Pharmaceuticals Gmbh |
Análogos de oligorribonucleótidos inmunoestimulantes que contienen restos de oligofosfato modificados
|
US8575121B2
(en)
|
2007-11-12 |
2013-11-05 |
The United States of America as represented by the Secetary of the Department of Health and Human Services |
Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
|
US8357501B2
(en)
|
2007-11-29 |
2013-01-22 |
Molecular Health Gmbh |
Tissue protective erythropoietin receptor (NEPOR) and methods of use
|
WO2009068677A1
(en)
|
2007-11-29 |
2009-06-04 |
Alepor Gmbh & Co. Kg |
Novel tissue protective erythropoietin receptor (nepor) and methods of use
|
GB0725321D0
(en)
|
2007-12-31 |
2008-02-06 |
Syntaxin Ltd |
Delivery vehicles
|
KR101483715B1
(ko)
|
2008-01-31 |
2015-01-19 |
큐어백 게엠바하 |
면역증강제/애주번트인 화학식(NuGlXmGnNv)a를 포함하는 핵산 및 이의 유도체
|
EP3581656B1
(en)
|
2008-05-21 |
2021-11-24 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
5' triphosphate oligonucleotide with blunt end and uses thereof
|
EP2297323A1
(en)
*
|
2008-05-21 |
2011-03-23 |
Hartmann, Gunther |
5' triphosphate oligonucleotide with blunt end and uses thereof
|
CA2635187A1
(en)
|
2008-06-05 |
2009-12-05 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Oligonucleotide duplexes and uses thereof
|
WO2009151600A2
(en)
|
2008-06-10 |
2009-12-17 |
Tufts University |
Smad proteins control drosha-mediated mirna maturation
|
CN101632833B
(zh)
|
2008-07-25 |
2013-11-06 |
上海市计划生育科学研究所 |
一种***癌相关的基因及其用途
|
WO2011028218A1
(en)
*
|
2009-09-02 |
2011-03-10 |
Alnylam Pharmaceuticals, Inc. |
Process for triphosphate oligonucleotide synthesis
|
AU2009288078B2
(en)
|
2008-09-02 |
2014-10-30 |
Alnylam Pharmaceuticals, Inc. |
Synthetic methods and derivatives of triphosphate oligonucleotides
|
WO2010042749A2
(en)
|
2008-10-08 |
2010-04-15 |
Chimeros Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
WO2010042755A2
(en)
|
2008-10-08 |
2010-04-15 |
Chimeros Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
WO2010042751A2
(en)
|
2008-10-08 |
2010-04-15 |
Chimeros Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
WO2010042742A2
(en)
|
2008-10-08 |
2010-04-15 |
Chimeros Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
CN102264898B
(zh)
|
2008-10-23 |
2013-10-16 |
国立大学法人东京大学 |
微小rna的功能抑制方法
|
WO2010062502A1
(en)
|
2008-11-03 |
2010-06-03 |
University Of Utah Research Foundation |
Carriers for the delivery of nucleic acids to cells and methods of use thereof
|
US20120027753A1
(en)
|
2009-02-26 |
2012-02-02 |
The Ohio State University |
MicroRNAs in Never-Smokers and Related Materials and Methods
|
WO2010118263A1
(en)
|
2009-04-08 |
2010-10-14 |
University Of Massachusetts |
Single-nucleotide polymorphism (snp) targeting therapies for the treatment of huntington's disease
|
WO2010120874A2
(en)
|
2009-04-14 |
2010-10-21 |
Chimeros, Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
US20100323018A1
(en)
|
2009-06-17 |
2010-12-23 |
Massachusetts Institute Of Technology |
Branched DNA/RNA monomers and uses thereof
|
ATE554749T1
(de)
|
2009-07-09 |
2012-05-15 |
Marina Biotech Inc |
Nachahmung von lipoproteinstrukturen
|
US9238811B2
(en)
|
2009-07-14 |
2016-01-19 |
Northeastern University |
siRNA phospholipid conjugate
|
EP2456869A4
(en)
|
2009-07-23 |
2013-11-27 |
Trustees Of The University Of Princeton |
MTOR KINASE HEMMER AS ANTIVIRUS AGENT
|
WO2011028128A1
(en)
*
|
2009-09-01 |
2011-03-10 |
Askim Frukt- Og Bærpresseri As |
Method to prevent oxidation of components in oil, and method to reduce the use of ethoxyquin to prevent oxidation of components in oil
|
EP2327783A1
(en)
|
2009-11-27 |
2011-06-01 |
Universitätsklinikum Freiburg |
Pharmaceutical composition comprising miRNA-100 and its use in the modulation of blood vessel growth
|
DE202009015670U1
(de)
|
2009-11-30 |
2011-04-14 |
Mcairlaid's Vliesstoffe Gmbh & Co. Kg |
Absorptionskörper zur Auflage auf Wunden
|
US20110247091A1
(en)
|
2010-03-26 |
2011-10-06 |
The Governors Of The University Of Alberta |
Transgenic Cells and Chickens Expressing RIG-I
|
WO2011133559A2
(en)
|
2010-04-19 |
2011-10-27 |
University Of Georgia Research Foundation, Inc. |
Alpha tubulin acetyltransferase
|
CN102985546A
(zh)
|
2010-05-04 |
2013-03-20 |
圣诺制药公司 |
TGF-beta和Cox-2抑制剂的联合及其治疗应用的方法
|
EP2385120A1
(en)
|
2010-05-04 |
2011-11-09 |
Justus-Liebig- Universitat Giessen |
Use of anti-miRNA antisense oligonucleotides for the treatment of pulmonary hypertension
|
CN101974529B
(zh)
|
2010-09-21 |
2013-04-03 |
南京大学(苏州)高新技术研究院 |
含自由三磷酸基团的TGF-β特异性siRNA及其应用
|
WO2012056440A1
(en)
|
2010-10-28 |
2012-05-03 |
Nanodoc Ltd. |
COMPOSITIONS AND METHODS FOR ACTIVATING EXPRESSION BY A SPECIFIC ENDOGENOUS miRNA
|
WO2012056441A1
(en)
|
2010-10-28 |
2012-05-03 |
Nanodoc Ltd. |
Compositions and methods for specific cleavage of exogenous rna in a cell
|
CN102475892A
(zh)
|
2010-11-22 |
2012-05-30 |
大连创达技术交易市场有限公司 |
作为制备抗癌药物的反义miRNA-210的用途
|
EP3695850A1
(en)
|
2010-12-30 |
2020-08-19 |
Samyang Biopharmaceuticals Corporation |
Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
|
US8461224B2
(en)
|
2011-03-04 |
2013-06-11 |
National Health Research Institutes |
Single monomer derived linear-like copolymer comprising polyethylenimine and poly(ethylene glycol) for nucleic acid delivery
|
WO2012125987A2
(en)
|
2011-03-17 |
2012-09-20 |
Massachusetts Institute Of Technology |
Delivery system
|
EP2508530A1
(en)
*
|
2011-03-28 |
2012-10-10 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Purification of triphosphorylated oligonucleotides using capture tags
|
JP2014520506A
(ja)
|
2011-07-04 |
2014-08-25 |
コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション |
核酸複合体
|
EP2551354A1
(en)
|
2011-07-25 |
2013-01-30 |
Universität Heidelberg |
Functionalization of RNA oligonucleotides
|
US20130189367A1
(en)
|
2011-07-29 |
2013-07-25 |
University Of Washington Through Its Center For Commercialization |
Nanovectors for targeted gene silencing and cytotoxic effect in cancer cells
|
EP2741783B1
(de)
|
2011-08-08 |
2017-03-22 |
Universität Regensburg |
Polyanion-nanokomplexe für therapeutische anwendungen
|
WO2013053481A1
(de)
|
2011-10-11 |
2013-04-18 |
Secutech International Pte. Ltd. |
Dimethylsulfoxid als lösungsmittel für nukleinsäuren
|
WO2013053480A1
(de)
|
2011-10-11 |
2013-04-18 |
Secutech International Pte. Ltd. |
Zusammensetzung zur einbringung von nukleinsäuren in zellen
|
WO2013064584A1
(en)
|
2011-10-31 |
2013-05-10 |
Riboxx Gmbh |
Double-stranded RNA for immunostimulation
|
WO2013075140A1
(en)
|
2011-11-17 |
2013-05-23 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Auto -recognizing therapeutic rna/dna chimeric nanoparticles (np)
|
JP2015518475A
(ja)
|
2012-04-10 |
2015-07-02 |
インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラルシェルシェ メディカル)Inserm(Institut National Dela Sante Etde La Recherche Medicale) |
非アルコール性脂肪性肝炎の治療方法
|
US20130302252A1
(en)
|
2012-05-11 |
2013-11-14 |
University Of Washington Through Its Center For Commercialization |
Polyarginine-coated magnetic nanovector and methods of use thereof
|
EP2712870A1
(en)
|
2012-09-27 |
2014-04-02 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Novel RIG-I ligands and methods for producing them
|
WO2014124433A1
(en)
|
2013-02-11 |
2014-08-14 |
Oregon Health & Science University |
5'-triphosphate oligoribonucleotides
|